Amgen to Test Psoriasis Drug Otezla as Possible COVID-19 Treatment

Amgen plans to test its blockbuster psoriasis drug Otezla (apremilast) as a possible COVID-19 treatment.

CEO Robert Bradway said the psoriasis drug could help prevent respiratory stress in late-stage COVID-19 patients. The company expects to begin trials of the drug in coming weeks. The company is looking to study the drug in multiple scenarios.